• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中PIK3CA和Akt/蛋白激酶B的分析

Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.

作者信息

Fenic Irina, Steger Klaus, Gruber Christin, Arens Christoph, Woenckhaus Joachim

机构信息

Department of Urology, University of Giessen, 35392 Giessen, Germany.

出版信息

Oncol Rep. 2007 Jul;18(1):253-9.

PMID:17549376
Abstract

PIK3CA, which encodes the catalytic subunit, p110-alpha, of phosphatidylinositol 3-kinase (PI3K), is implicated in the development and progression of numerous neoplasias including head and neck squamous cell carcinoma (HNSCC). In the present study, we investigated the occurrence of PIK3CA hot-spot mutations in exons 9 and 20, the genomic gain and amplification of PIK3CA, the expression of PIK3CA mRNA and the p110 alpha protein, as well as the expression of phosphorylated-Akt (pAkt) in 33 cases of HNSCC and compared the results with the clinicopathological data. No non-synonymous mutations were detected. PIK3CA copy number gain and amplification were found in 36.4 and 9% of the cases, respectively, whereas mRNA overexpression was observed in 48.5% of the cases. No correlations could be stated between DNA gain, DNA amplification and mRNA expression, either between DNA or mRNA status and p110 alpha expression. Direct associations were found between PIK3CA gain and lymph node metastases (p=0.025) and between mRNA expression and tumour stage (p=0.015). A strong correlation was detected between p110 alpha and pAkt expression (p<0.001). Concluding, PIK3CA could be an oncogene implicated in HNSCC development. However, our data suggest that amplifications or mutations of this gene seldom occur in HNSCC and that epigenetic events can play an important role in advanced tumour stages.

摘要

磷脂酰肌醇3激酶(PI3K)的催化亚基p110-α由PIK3CA编码,它与包括头颈部鳞状细胞癌(HNSCC)在内的多种肿瘤的发生和发展有关。在本研究中,我们调查了33例HNSCC中PIK3CA第9和20外显子热点突变的发生情况、PIK3CA的基因组增加和扩增、PIK3CA mRNA和p110α蛋白的表达以及磷酸化Akt(pAkt)的表达,并将结果与临床病理数据进行比较。未检测到非同义突变。分别在36.4%和9%的病例中发现PIK3CA拷贝数增加和扩增,而在48.5%的病例中观察到mRNA过表达。DNA增加、DNA扩增与mRNA表达之间,DNA或mRNA状态与p110α表达之间均无相关性。发现PIK3CA增加与淋巴结转移之间存在直接关联(p=0.025),mRNA表达与肿瘤分期之间存在直接关联(p=0.015)。检测到p110α与pAkt表达之间存在强相关性(p<0.001)。总之,PIK3CA可能是一种与HNSCC发生有关的癌基因。然而,我们的数据表明,该基因的扩增或突变在HNSCC中很少发生,表观遗传事件在晚期肿瘤阶段可能起重要作用。

相似文献

1
Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中PIK3CA和Akt/蛋白激酶B的分析
Oncol Rep. 2007 Jul;18(1):253-9.
2
Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.PIK3CA的基因组扩增和p110α表达增加与发育异常进展为浸润性鳞状细胞癌相关。
J Pathol. 2002 Nov;198(3):335-42. doi: 10.1002/path.1207.
3
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.新型癌基因鳞状细胞癌相关癌基因和磷脂酰肌醇3激酶p110α在舌鳞状细胞癌中的作用。
Clin Cancer Res. 2003 Jun;9(6):2300-6.
4
PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.位于3q的PIK3CA和TFRC是食管鳞状细胞癌新的预后因素。
Ann Surg Oncol. 2006 Jul;13(7):961-6. doi: 10.1245/ASO.2006.08.006. Epub 2006 May 16.
5
A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.头颈部鳞状细胞癌早期阶段染色体畸变的一种简单特定模式:PIK3CA基因而非p63基因可能是3q26 - qter区域扩增的靶点。
Cancer Res. 2001 May 15;61(10):4122-9.
6
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.NBS1表达增加是侵袭性头颈癌的一个标志物,且NBS1的过表达促成肿瘤转化。
Clin Cancer Res. 2006 Jan 15;12(2):507-15. doi: 10.1158/1078-0432.CCR-05-1231.
7
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中PIK3CA基因的致癌突变。
Int J Oncol. 2008 Jan;32(1):101-11.
8
Epithelial cell nicotinic acetylcholine receptor expression in head and neck squamous cell carcinoma pathogenesis.上皮细胞烟碱型乙酰胆碱受体表达在头颈部鳞状细胞癌发病机制中的作用
Anticancer Res. 2007 Mar-Apr;27(2):835-9.
9
Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中磷酸肌醇激酶-3状态与人乳头瘤病毒的存在与否相关。
Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S98-101. doi: 10.1016/j.ijrobp.2007.04.082.
10
Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.Kv3.4 钾通道亚基在头颈部鳞状细胞癌发生发展中的表达及临床意义。
J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

引用本文的文献

1
Impact of tobacco smoking on oral cancer genetics-A next-generation sequencing perspective.吸烟对口腔癌遗传学的影响——下一代测序视角
Imeta. 2022 Aug 4;1(3):e44. doi: 10.1002/imt2.44. eCollection 2022 Sep.
2
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.了解鳞状细胞癌中的 PI3K/Akt/mTOR 信号通路:以突变型 PIK3CA 为例。
Mol Biomed. 2024 Apr 15;5(1):13. doi: 10.1186/s43556-024-00176-0.
3
High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
高真核起始因子 5A2 的表达预示着不良预后,可能参与了头颈部鳞状细胞癌中的 SNHG16/miR-10b-5p/EIF5A2 调控轴。
J Clin Lab Anal. 2023 Jan;37(1):e24820. doi: 10.1002/jcla.24820. Epub 2022 Dec 22.
4
Molecular pathways modulated by phytochemicals in head and neck cancer.植物化学物质在头颈癌中调节的分子途径。
J Cell Commun Signal. 2023 Sep;17(3):469-483. doi: 10.1007/s12079-022-00711-0. Epub 2022 Dec 1.
5
Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development.鉴定并开发一种适合临床开发的亚型选择性别构 AKT 抑制剂。
Sci Rep. 2022 Sep 20;12(1):15715. doi: 10.1038/s41598-022-20208-5.
6
Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌的分子通路与可成药靶点
Cancers (Basel). 2021 Jul 9;13(14):3453. doi: 10.3390/cancers13143453.
7
Proto-Oncogenes and Cell Cycle Gene Expression in Normal and Neoplastic Oral Epithelial Cells Stimulated With Soluble Factors From Single and Dual Biofilms of and .原癌基因和细胞周期基因在正常和肿瘤口腔上皮细胞中的表达,这些细胞受到 和 单种和两种生物膜可溶性因子的刺激。
Front Cell Infect Microbiol. 2021 Feb 25;11:627043. doi: 10.3389/fcimb.2021.627043. eCollection 2021.
8
An Immunohistochemical Study of the PTEN/AKT Pathway Involvement in Canine and Feline Mammary Tumors.PTEN/AKT信号通路参与犬猫乳腺肿瘤的免疫组织化学研究
Animals (Basel). 2021 Feb 1;11(2):365. doi: 10.3390/ani11020365.
9
Prognostic value of the , , and mutations in oral squamous cell carcinoma: literature review.口腔鳞状细胞癌中 、 和 突变的预后价值:文献综述
Arch Med Sci. 2020 Nov 13;17(1):207-217. doi: 10.5114/aoms.2020.100780. eCollection 2021.
10
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?PIK3CA和PTEN生物标志物在口腔鳞状细胞癌预后中起作用吗?
Life (Basel). 2020 Dec 3;10(12):325. doi: 10.3390/life10120325.